Results
|
1.
|
How should one measure and how low should the urinary iodine excretion be prior to radioiodine imaging and/or therapy in patients with differentiated thyroid cancer? An educational exhibit MedStar authors:
- Bethancourt, E
- Burman, Kenneth D
- Moreau, Shari
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Moreau S, Guan H, Burman K, Wartofsky L, Van Nostrand D
|
|
2.
|
The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer MedStar authors:
- Bethancourt, E
- Burman, Kenneth D
- Garcia, Carlos
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wexler, Jason
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Garcia CA, Van Nostrand D, Wexler JA, Bethancourt E, Burman k, Wartofsky l
|
|
3.
|
The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
4.
|
The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|